For: | Manzoor S, Saalim M, Imran M, Resham S, Ashraf J. Hepatitis B virus therapy: What’s the future holding for us? World J Gastroenterol 2015; 21(44): 12558-12575 [PMID: 26640332 DOI: 10.3748/wjg.v21.i44.12558] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i44/12558.htm |
Number | Citing Articles |
1 |
Shaghayegh Gorji, Ahmad Fakharian, Rezvan Abbasi. Passive observer-based controller design for a class of Lipschitz nonlinear time-varying systems with application to Hepatitis B disease. Proceedings of the Institution of Mechanical Engineers, Part I: Journal of Systems and Control Engineering 2024; 238(8): 1486 doi: 10.1177/09596518241236925
|
2 |
Aina-Cathrine Øvergård, Lars Are Hamre, Heidi Kongshaug, Frank Nilsen. RNAi-mediated treatment of two vertically transmitted rhabdovirus infecting the salmon louse (Lepeophtheirus salmonis). Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14282-3
|
3 |
James Fung, Ching-Lung Lai, Wai-Kay Seto, Man-Fung Yuen. Emerging drugs for the treatment of hepatitis B. Expert Opinion on Emerging Drugs 2016; 21(2): 183 doi: 10.1517/14728214.2016.1162155
|
4 |
Jung-Ah Kang, Songwon Kim, Minji Park, Hyun-Jin Park, Jeong-Hyun Kim, Sanghyeok Park, Jeong-Ryul Hwang, Yong-Chul Kim, Yoon Jun Kim, Yuri Cho, Mi Sun Jin, Sung-Gyoo Park. Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-10200-5
|
5 |
Sebastien Boucle, Leda Bassit, Maryam Ehteshami, Raymond F. Schinazi. Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined Modalities. Clinics in Liver Disease 2016; 20(4): 737 doi: 10.1016/j.cld.2016.07.001
|
6 |
Xiaojun Sun, Chengwei Wang, Bian Wang, Xiuzhen Yang, Hongtao Xu, Meilong Shen, Kuichun Zhu, Susan Cu-Uvin. Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group. Infectious Diseases in Obstetrics and Gynecology 2020; 2020: 1 doi: 10.1155/2020/4305950
|
7 |
Yin Zhang, Yanming Xie, Yiying Zhang, Yan Liu, Yan Zhuang. Hepatitis B patients exhibiting mild alanine aminotransferase elevation: A comparative analysis of treatment with and without Bicyclol tablets. Biomedical Reports 2016; 5(5): 595 doi: 10.3892/br.2016.765
|
8 |
Young Li, Yang Wu, Xiaohu Zheng, Jingjing Cong, Yanyan Liu, Jiabin Li, Rui Sun, Zhigang G. Tian, Haiming M. Wei. Cytoplasm-Translocated Ku70/80 Complex Sensing of HBV DNA Induces Hepatitis-Associated Chemokine Secretion. Frontiers in Immunology 2016; 7 doi: 10.3389/fimmu.2016.00569
|
9 |
Haiyong Jia, Yang Song, Ji Yu, Peng Zhan, Diwakar Rai, Xiaohong Liang, Chunhong Ma, Xinyong Liu. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors. European Journal of Medicinal Chemistry 2017; 136: 144 doi: 10.1016/j.ejmech.2017.04.048
|
10 |
Lixia Gao, Jie Yang, Jutao Feng, Ziying Liu, Ying Dong, Jiangyan Luo, Liangzhentian Yu, Jiamei Wang, Hongying Fan, Weifeng Ma, Tiancai Liu. PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.856463
|
11 |
Jing Tu, Jiao Jiao Li, Zhi Jie Shan, Hong Lin Zhai. Exploring the binding mechanism of Heteroaryldihydropyrimidines and Hepatitis B Virus capsid combined 3D-QSAR and molecular dynamics. Antiviral Research 2017; 137: 151 doi: 10.1016/j.antiviral.2016.11.026
|
12 |
Sei Yonezawa, Hiroyuki Koide, Tomohiro Asai. Recent advances in siRNA delivery mediated by lipid-based nanoparticles. Advanced Drug Delivery Reviews 2020; : 64 doi: 10.1016/j.addr.2020.07.022
|
13 |
MERYEM GUVENIR, AYSE ARIKAN. Hepatitis B Virus: From Diagnosis to Treatment. Polish Journal of Microbiology 2020; 69(4): 391 doi: 10.33073/pjm-2020-044
|
14 |
Jingying Qiu, Qineng Gong, Jian Gao, Wang Chen, Yinpeng Zhang, Xiaoke Gu, Daoquan Tang. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors. European Journal of Medicinal Chemistry 2018; 144: 424 doi: 10.1016/j.ejmech.2017.12.042
|
15 |
Soo-Hyun Park, Kyung-Seok Park, Nam-Hee Kim, Joong-Yang Cho, Moon Soo Koh, Jin Ho Lee. Clevudine Induced Mitochondrial Myopathy. Journal of Korean Medical Science 2017; 32(11): 1857 doi: 10.3346/jkms.2017.32.11.1857
|
16 |
Dongki Yang. Application of Nanotechnology in the COVID-19 Pandemic. International Journal of Nanomedicine 2021; : 623 doi: 10.2147/IJN.S296383
|
17 |
Lavanya Singh, Hendrik G. Kruger, Glenn E.M. Maguire, Thavendran Govender, Raveen Parboosing. The role of nanotechnology in the treatment of viral infections. Therapeutic Advances in Infectious Disease 2017; 4(4): 105 doi: 10.1177/2049936117713593
|
18 |
Shaghayegh Gorji, Ahmad Fakharian, Rezvan Abbasi. Virtually Euler–Lagrange form for feedback passivation of a wide range of non-Euler–Lagrange systems: Adaptive passivity-based control of hepatitis B disease. Proceedings of the Institution of Mechanical Engineers, Part I: Journal of Systems and Control Engineering 2023; 237(7): 1313 doi: 10.1177/09596518221146928
|
19 |
Jonathan Forde, Stanca Ciupe, Ariel Cintron-Arias, Suzanne Lenhart. Optimal Control of Drug Therapy in a Hepatitis B Model. Applied Sciences 2016; 6(8): 219 doi: 10.3390/app6080219
|
20 |
Yudha Gusti Wibowo, Bimastyaji Surya Ramadan, Tarmizi Taher, Khairurrijal Khairurrijal. Advancements of Nanotechnology and Nanomaterials in Environmental and Human Protection for Combatting the COVID-19 During and Post-pandemic Era: A Comprehensive Scientific Review. Biomedical Materials & Devices 2024; 2(1): 34 doi: 10.1007/s44174-023-00086-9
|
21 |
Wu Guicheng, An Xuan, Xiang Yi, Wei Fang, Xia Lina, Zhong Qing, Du Biao, Liu Yong. Effect of Cytotoxic T Lymphocytes Induced by Recombinant Adeno-Associated Virus on Different Hepatitis B Virus Genes. Hepatitis Monthly 2016; 17(5) doi: 10.5812/hepatmon.42685
|
22 |
Uma S. Singh, Varughese A. Mulamoottil, Chung K. Chu. 2′‐Fluoro‐6′‐methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti‐HBV agent, active against drug‐resistant HBV mutants. Medicinal Research Reviews 2018; 38(3): 977 doi: 10.1002/med.21490
|
23 |
Pranav Kumar Prabhakar, Navneet Khurana, Manish Vyas, Vikas Sharma, Gaber El-Saber Batiha, Harpreet Kaur, Jashanpreet Singh, Deepak Kumar, Neha Sharma, Ajeet Kaushik, Raj Kumar. Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications. Pharmaceutics 2023; 15(2): 451 doi: 10.3390/pharmaceutics15020451
|
24 |
Yongning Xin, Wei Li, Linlin Lu, Li Zhou, David W. Victor, Shiying Xuan. Antiviral effects of Stichopus japonicus acid mucopolysaccharide on hepatitis B virus transgenic mice. Journal of Ocean University of China 2016; 15(4): 719 doi: 10.1007/s11802-016-3124-4
|
25 |
Hyun Jung Jo, Gyu Nam Park, Hye Ran Kim, Min Ju Kim, Kyung A Shin, Seung Bok Hong, Kyung Soo Chang. Differences in Hematological Characteristics, Including Cholesterol and Apolipoprotein B and E, between Hepatitis B Virus and Hepatitis C Virus Patients in Korea. Journal of Bacteriology and Virology 2016; 46(3): 152 doi: 10.4167/jbv.2016.46.3.152
|
26 |
Sana Mansha, Muhammad Imran, Amir Miraj Ul Hussain Shah, Muhsin Jamal, Fayyaz Ahmed, Muhammad Atif, Muhammmad Saleem, Sher Zaman Safi, Zareen Fatima, Ahmed Bilal Waqar. Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, Pakistan. Viral Immunology 2017; 30(5): 366 doi: 10.1089/vim.2016.0144
|
27 |
Ting Yuan, Yongfang Jiang, Mei Li, Wei Li. Chronic hepatitis B surface antigen seroclearance‐related immune factors. Hepatology Research 2017; 47(1): 49 doi: 10.1111/hepr.12726
|
28 |
Shrihari A. Anikhindi, Ashish Kumar, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora. Ideal Cure for Hepatitis B Infection: The Target is in Sight. Journal of Clinical and Experimental Hepatology 2018; 8(2): 188 doi: 10.1016/j.jceh.2017.10.002
|
29 |
涛 巫. Immunotherapy for Chronic Hepatitis B Virus Infection. Pharmacy Information 2019; 8(03): 105 doi: 10.12677/PI.2019.83013
|
30 |
Naoki Takizawa, Manabu Yamasaki. Current landscape and future prospects of antiviral drugs derived from microbial products. The Journal of Antibiotics 2018; 71(1): 45 doi: 10.1038/ja.2017.115
|
31 |
Claire Pierra Rouviere, Cyril B. Dousson, John E. Tavis. HBV replication inhibitors. Antiviral Research 2020; 179: 104815 doi: 10.1016/j.antiviral.2020.104815
|
32 |
Yunwen Wang, Shendan Wang, Xuefen Tao, Yuan Wang, Yuxuan Wu, Na Chen, Chenxian Hu, Hao Wang, Shuang Yu, Rong Sheng. The SAR-based development of small molecular HBV capsid assembly modulators. Medicinal Chemistry Research 2022; 31(9): 1414 doi: 10.1007/s00044-022-02936-5
|
33 |
Akriti Rai, Kamal Shah, Rajiv Sharma, Hitesh Kumar Dewangan. A Comprehensive Review on COVID-19: Emphasis on Current Vaccination
and Nanotechnology Aspects. Recent Patents on Nanotechnology 2023; 17(4): 359 doi: 10.2174/1872210516666220819104853
|
34 |
Hafiz Ullah, Amin Ullah, Hadia Gul, Rahat Ullah Khan, Junaid Ahmad, Rafa Almeer, Khurshid Alam, Muhammad Ayaz, Muhammad Ajmal Khan, Zafar Abbass Shah. Interferon-stimulated gene (ISG12a) suppresses hepatitis B virus replication in Huh 7 cells line. Journal of King Saud University - Science 2024; 36(9): 103377 doi: 10.1016/j.jksus.2024.103377
|
35 |
Andrea Carracedo Rodriguez, Matthias Chung, Stanca Ciupe. Understanding the Complex Patterns Observed during Hepatitis B Virus Therapy. Viruses 2017; 9(5): 117 doi: 10.3390/v9050117
|
36 |
菁 何. Advances in Diagnostic Technique and Pharmacological Therapy of Hepatitis B. Advances in Clinical Medicine 2024; 14(06): 643 doi: 10.12677/acm.2024.1461821
|